1
|
Wang XJ, Ren JL, Zhang AH, Sun H, Yan GL, Han Y, Liu L. Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence. MASS SPECTROMETRY REVIEWS 2019; 38:380-402. [PMID: 30817039 DOI: 10.1002/mas.21589] [Citation(s) in RCA: 69] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/01/2018] [Accepted: 01/25/2019] [Indexed: 06/09/2023]
Abstract
Current evidence shows that herbal medicines could be beneficial for the treatment of various diseases. However, the complexities present in chemical compositions of herbal medicines are currently an obstacle for the progression of herbal medicines, which involve unclear bioactive compounds, mechanisms of action, undetermined targets for therapy, non-specific features for drug metabolism, etc. To overcome those issues, metabolomics can be a great to improve and understand herbal medicines from the small-molecule metabolism level. Metabolomics could solve scientific difficulties with herbal medicines from a metabolic perspective, and promote drug discovery and development. In recent years, mass spectrometry-based metabolomics was widely applied for the analysis of herbal constituents in vivo and in vitro. In this review, we highlight the value of mass spectrometry-based metabolomics and metabolism to address the complexity of herbal medicines in systems pharmacology, and to enhance their biomedical value in biomedicine, to shed light on the aid that mass spectrometry-based metabolomics can offer to the investigation of its active ingredients, especially, to link phytochemical analysis with the assessment of pharmacological effect and therapeutic potential. © 2019 Wiley Periodicals, Inc. Mass Spec Rev.
Collapse
Affiliation(s)
- Xi-Jun Wang
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau
- National Engineering Laboratory for the Development of Southwestern Endangered Medicinal Materials, Guangxi Botanical Garden of Medicinal Plant, Nanning Guangxi, China
| | - Jun-Ling Ren
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
| | - Ai-Hua Zhang
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
| | - Hui Sun
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
| | - Guang-Li Yan
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
| | - Ying Han
- National Chinmedomics Research Center, Sino-America Chinmedomics Technology Collaboration Center, National TCM Key Laboratory of Serum Pharmacochemistry, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin, 150040, China
| | - Liang Liu
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau
| |
Collapse
|
2
|
He XR, Li CG, Zhu XS, Li YQ, Jarouche M, Bensoussan A, Li PP. High-performance liquid chromatography coupled with tandem mass spectrometry technology in the analysis of Chinese Medicine Formulas: A bibliometric analysis (1997-2015). J Sep Sci 2016; 40:81-92. [PMID: 27731929 DOI: 10.1002/jssc.201600784] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2016] [Revised: 09/19/2016] [Accepted: 10/05/2016] [Indexed: 12/23/2022]
Abstract
There is a recognized challenge in analyzing traditional Chinese medicine formulas because of their complex chemical compositions. The application of modern analytical techniques such as high-performance liquid chromatography coupled with a tandem mass spectrometry has improved the characterization of various compounds from traditional Chinese medicine formulas significantly. This study aims to conduct a bibliometric analysis to recognize the overall trend of high-performance liquid chromatography coupled with tandem mass spectrometry approaches in the analysis of traditional Chinese medicine formulas, its significance and possible underlying interactions between individual herbs in these formulas. Electronic databases were searched systematically, and the identified studies were collected and analyzed using Microsoft Access 2010, Graph Pad 5.0 software and Ucinet software package. 338 publications between 1997 and 2015 were identified, and analyzed in terms of annual growth and accumulated publications, top journals, forms of traditional Chinese medicine preparations and highly studied formulas and single herbs, as well as social network analysis of single herbs. There is a significant increase trend in using high-performance liquid chromatography coupled with tandem mass spectrometry related techniques in analysis of commonly used forms of traditional Chinese medicine formulas in the last 3 years. Stringent quality control is of great significance for the modernization and globalization of traditional Chinese medicine, and this bibliometric analysis provided the first and comprehensive summary within this field.
Collapse
Affiliation(s)
- Xi-Ran He
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Peking University Cancer Hospital & Institute, Beijing, China
| | - Chun-Guang Li
- National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, Australia
| | - Xiao-Shu Zhu
- National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, Australia
| | - Yuan-Qing Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Peking University Cancer Hospital & Institute, Beijing, China
| | - Mariam Jarouche
- National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, Australia
| | - Alan Bensoussan
- National Institute of Complementary Medicine, Western Sydney University, Campbelltown, NSW, Australia
| | - Ping-Ping Li
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Peking University Cancer Hospital & Institute, Beijing, China
| |
Collapse
|
3
|
Cui K, Sun S, Wang P, Luo L, Yu J, Guo X. A novel UPLC-MS/MS method for simultaneous determination of 10 effective constituents in the Jixingshizhen preparation. Biomed Chromatogr 2016; 31. [DOI: 10.1002/bmc.3854] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2016] [Revised: 08/31/2016] [Accepted: 09/15/2016] [Indexed: 11/10/2022]
Affiliation(s)
- Kunna Cui
- Shenyang Pharmaceutical University; Shenyang People's Republic of China
| | - Shuo Sun
- Shenyang Pharmaceutical University; Shenyang People's Republic of China
| | - Ping Wang
- Shenyang Pharmaceutical University; Shenyang People's Republic of China
| | - Linda Luo
- Shenyang Pharmaceutical University; Shenyang People's Republic of China
| | - Jia Yu
- Department of Analytical Chemistry; Shenyang Pharmaceutical University; Shenyang People's Republic of China
| | - Xingjie Guo
- Department of Analytical Chemistry; Shenyang Pharmaceutical University; Shenyang People's Republic of China
| |
Collapse
|
4
|
Identification of the constituents and metabolites in rat plasma after oral administration of HuanglianShangqing pills by ultra high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 2016; 125:194-204. [DOI: 10.1016/j.jpba.2016.03.038] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Revised: 03/17/2016] [Accepted: 03/18/2016] [Indexed: 11/18/2022]
|
5
|
Ma YC, Mani A, Cai Y, Thomson J, Ma J, Peudru F, Chen S, Luo M, Zhang J, Chapman RG, Shi ZT. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2016; 23:377-387. [PMID: 27002408 DOI: 10.1016/j.phymed.2016.02.003] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2015] [Revised: 02/03/2016] [Accepted: 02/04/2016] [Indexed: 06/05/2023]
Abstract
BACKGROUND Ginkgo biloba L. (Ginkgoaceae) leaf extract is one of the most popular herbal products on the market, as it contains flavone glycosides (≥ 24%) and terpene lactones (≥ 6%), which are proposed to have significant physiological effects. Unfortunately, the challenging financial climate has resulted in a natural health product market containing adulterated ginkgo products. PURPOSE 42 ginkgo samples were analyzed to establish an HPLC profile for authentic ginkgo and common ginkgo adulterants, and to develop a method capable of easily detecting adulteration in ginkgo commercial products. METHOD In this study an efficient and targeted HPLC analysis method was established that is capable of distinguishing flavonol glycosides and aglycones simultaneously for the evaluation of ginkgo powdered extracts (PEs) and finished products in a single, 13 min run. Thirteen ginkgo leaf samples, fifteen standardized powdered extracts, and fourteen commercially available ginkgo products have been analyzed using this new HPLC method. Chromatograms were compared to six standard reference materials: one flavonol glycoside (rutin), three aglycones (quercetin, kaempferol and isorhamnetin), and two isoflavones (genestin and genistein). The quantitative chromatographic data was interpreted by principal component analysis (PCA), which assisted in the detection of unexpected chromatographic features in various adulterated botanical products. RESULTS Only three of the commercially available ginkgo finished products tested in this study were determined to be authentic, with flavonol glycoside rutin, and aglycones quercetin, kaempferol, and isorhamnetin found to be common adulterants in the ginkgo powdered extract and finished product samples. CONCLUSION Despite evidence of adulteration in most of the samples, each of the samples discussed herein met most of the current pharmacopeial standards. It is therefore critical that a preliminary evaluation be utilized to detect adulteration in commercial ginkgo products, prior to the acid hydrolysis procedure utilized in the current testing methods.
Collapse
Affiliation(s)
- Yuan-Chun Ma
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada; Canadian Institute of Medicinal Plants, 12233 Riverside Way, Richmond, BC V6W 1K8, Canada; Hubei University of Chinese Medicine, Wuhan 430000, PR China.
| | - Ana Mani
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada.
| | - Yaling Cai
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada; Canadian Institute of Medicinal Plants, 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Jaclyn Thomson
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Jie Ma
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada; Canadian Institute of Medicinal Plants, 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Flavie Peudru
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Sarah Chen
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Mai Luo
- Canadian Phytopharmaceuticals Corp., 12233 Riverside Way, Richmond, BC V6W 1K8, Canada; Canadian Institute of Medicinal Plants, 12233 Riverside Way, Richmond, BC V6W 1K8, Canada
| | - Junzeng Zhang
- Natural Health Products Program, Aquatic and Crop Resource Development, National Research Council of Canada, Halifax, Nova Scotia B3H 3Z1, Canada
| | - Robert G Chapman
- Natural Health Products Program, Aquatic and Crop Resource Development, National Research Council of Canada, Halifax, Nova Scotia B3H 3Z1, Canada
| | - Zhen-Tuo Shi
- Hubei Nuokete Pharmaceutical Co., Ltd., Xiaochang, Hubei 432900, PR China
| |
Collapse
|